Kelly J Rohan1, Jennifer N Mahon1, Maggie Evans1, Sheau-Yan Ho1, Jonah Meyerhoff1, Teodor T Postolache1, Pamela M Vacek1. 1. From the Department of Psychological Science, University of Vermont, and the Department of Medical Biostatistics, University of Vermont College of Medicine, Burlington, Vt.; the Department of Psychiatry, University of Maryland School of Medicine, Baltimore; and Veterans Integrated Service Network (VISN) 5, Mental Illness Research Education and Clinical Center (MIRECC), Baltimore, and VISN 19 Rocky Mountain MIRECC, Denver.
Abstract
OBJECTIVE: Whereas considerable evidence supports light therapy for winter seasonal affective disorder (SAD), data on cognitive-behavioral therapy for SAD (CBT-SAD) are promising but preliminary. This study estimated the difference between CBT-SAD and light therapy outcomes in a large, more definitive test. METHOD: The participants were 177 adults with a current episode of major depression that was recurrent with a seasonal pattern. The randomized clinical trial compared 6 weeks of CBT-SAD (N=88) and light therapy (N=89). Light therapy consisted of 10,000-lux cool-white florescent light, initiated at 30 minutes each morning and adjusted according to a treatment algorithm based on response and side effects. CBT-SAD comprised 12 sessions of the authors' SAD-tailored protocol in a group format and was administered by Ph.D. psychologists in two 90-minute sessions per week. Outcomes were continuous scores on the Structured Interview Guide for the Hamilton Rating Scale for Depression-SAD Version (SIGH-SAD, administered weekly) and Beck Depression Inventory-Second Edition (BDI-II, administered before treatment, at week 3, and after treatment) and posttreatment remission status based on cut points. RESULTS:Depression severity measured with the SIGH-SAD and BDI-II improved significantly and comparably with CBT-SAD and light therapy. Having a baseline comorbid diagnosis was associated with higher depression scores across all time points in both treatments. CBT-SAD and light therapy did not differ in remission rates based on the SIGH-SAD (47.6% and 47.2%, respectively) or the BDI-II (56.0% and 63.6%). CONCLUSIONS:CBT-SAD and light therapy are comparably effective for SAD during an acute episode, and both may be considered as treatment options.
RCT Entities:
OBJECTIVE: Whereas considerable evidence supports light therapy for winter seasonal affective disorder (SAD), data on cognitive-behavioral therapy for SAD (CBT-SAD) are promising but preliminary. This study estimated the difference between CBT-SAD and light therapy outcomes in a large, more definitive test. METHOD: The participants were 177 adults with a current episode of major depression that was recurrent with a seasonal pattern. The randomized clinical trial compared 6 weeks of CBT-SAD (N=88) and light therapy (N=89). Light therapy consisted of 10,000-lux cool-white florescent light, initiated at 30 minutes each morning and adjusted according to a treatment algorithm based on response and side effects. CBT-SAD comprised 12 sessions of the authors' SAD-tailored protocol in a group format and was administered by Ph.D. psychologists in two 90-minute sessions per week. Outcomes were continuous scores on the Structured Interview Guide for the Hamilton Rating Scale for Depression-SAD Version (SIGH-SAD, administered weekly) and Beck Depression Inventory-Second Edition (BDI-II, administered before treatment, at week 3, and after treatment) and posttreatment remission status based on cut points. RESULTS:Depression severity measured with the SIGH-SAD and BDI-II improved significantly and comparably with CBT-SAD and light therapy. Having a baseline comorbid diagnosis was associated with higher depression scores across all time points in both treatments. CBT-SAD and light therapy did not differ in remission rates based on the SIGH-SAD (47.6% and 47.2%, respectively) or the BDI-II (56.0% and 63.6%). CONCLUSIONS: CBT-SAD and light therapy are comparably effective for SAD during an acute episode, and both may be considered as treatment options.
Authors: Kelly J Rohan; Kathryn A Roecklein; Kathryn Tierney Lindsey; Leigh G Johnson; Robert D Lippy; Timothy J Lacy; Franca B Barton Journal: J Consult Clin Psychol Date: 2007-06
Authors: Robert N Golden; Bradley N Gaynes; R David Ekstrom; Robert M Hamer; Frederick M Jacobsen; Trisha Suppes; Katherine L Wisner; Charles B Nemeroff Journal: Am J Psychiatry Date: 2005-04 Impact factor: 18.112
Authors: Kelly J Rohan; Maggie Evans; Jennifer N Mahon; Lilya Sitnikov; Sheau-Yan Ho; Yael I Nillni; Teodor T Postolache; Pamela M Vacek Journal: Trials Date: 2013-03-21 Impact factor: 2.279
Authors: Kelly J Rohan; Jonah Meyerhoff; Sheau-Yan Ho; Kathryn A Roecklein; Yael I Nillni; Joel J Hillhouse; Michael J DeSarno; Pamela M Vacek Journal: Psychol Assess Date: 2019-03-28
Authors: Arun V Ravindran; Lynda G Balneaves; Guy Faulkner; Abigail Ortiz; Diane McIntosh; Rachel L Morehouse; Lakshmi Ravindran; Lakshmi N Yatham; Sidney H Kennedy; Raymond W Lam; Glenda M MacQueen; Roumen V Milev; Sagar V Parikh Journal: Can J Psychiatry Date: 2016-08-02 Impact factor: 4.356
Authors: Anne Venner; William D Todd; Jimmy Fraigne; Hannah Bowrey; Ada Eban-Rothschild; Satvinder Kaur; Christelle Anaclet Journal: Sleep Date: 2019-05-01 Impact factor: 5.849